Giuseppe Mangioni

This paper uses a graph neural network to predict antibacterial activity against Acinetobacter baumannii and identifies piperazine as a key contributor to predicted activity, leading to the testing of CE3F4.

LLMsFold designs and validates new small molecules targeting pathogenic proteins using LLMs and biophysical simulations, showing strong in silico binding and drug-like profiles.